Apr 27, 2018 This Week in Cardiology

Lipid-lowering and baseline LDL-C, the CV safety of NSAIDs, 'metabolically healthy' obesity, PCI for chronic total occlusions, and wearable tech are discussed in this week's podcast.

After Stroke, Delaying SAVR Cuts Risk for New Stroke

The recurrent-stroke risk truly spikes at surgical aortic valve replacement within 3 months of a prior stroke, say researchers of a cohort study, cautioning that such SAVR be delayed 'at least 3 or 4 months.'

Tenecteplase: Thrombolytic of Choice in Stroke?

The EXTEND-IA TNK trial suggesting better outcomes with tenecteplase than alteplase in the treatment of acute ischemic stroke has now been published in the New England Journal of Medicine.

Pets, the not-so-secret weapon to help patients recover from what ails them

By AMERICAN HEART ASSOCIATION NEWS When Scott Vande Zande had a serious stroke 15 years ago, his beloved golden retriever Hollie was key to his recovery. “I had to learn to speak again, but there were times I couldn’t talk,” said the Seattle engineer. “I’d come home, and I was […]

PROGRESS CTO: PCI Successful in Nearly 9 of 10 CTOs

The results may provide important benchmarking for discussion about the risk:benefit ratio of the procedure, which has been called the last frontier of PCI and has yet to win over critics.

How black cardiologists are combating a heart problem affecting millions

By AMERICAN HEART ASSOCIATION NEWS Doctors and African-American communities are obligated to learn more about heart valve disease and the lifesaving procedures available to treat it, according to a report from the Association of Black Cardiologists. “It is incumbent upon us as health care providers [to] do a better job […]

CV Safety of Celecoxib Similar to Naproxen, Ibuprofen, FDA Panels Say

Two FDA panels jointly voted by a large margin that the cardiovascular safety of celecoxib is comparable to naproxen and ibuprofen.